Thursday, November 01, 2018 6:38:05 AM
4:00 pm ET October 31, 2018 (Globe Newswire) Print
Expects Record Year Driven by Solesence and Mineral UV Absorber Growth
The Company's financial conference call is scheduled for November 1, 2018 at 11am EDT
Nanophase Technologies Corporation (OTCQB: NANX), a leader in minerals-based personal care ingredients and formulated products for protecting skin from environmental aggressors such as UV light and pollution, today reported financial results for the third quarter ended September 30, 2018.
"Through our first Solesence product launches, our patented and proprietary Active Stress Defense Technology is being well received in the market," commented Nanophase CEO and President Jess Jankowski. "We are awaiting feedback regarding follow-on volume for 2019. Solesence revenue made up more than 10% of our total revenue over the past two quarters, and we expect ongoing sales from our initial launches, plus revenue from a new clients' upcoming launch, to have a positive impact on Q4 results."
"Total revenue in Q318 has been most significantly driven by the continued strength of our minerals-based active ingredients in the various sun- and skin-care markets. We expect consumer awareness of the positive effects of minerals-based versus chemicals-based UV protection to continue to grow over time. Within our product portfolio, we feel our zinc oxide active ingredients and formulated finished products will continue to benefit from this market shift."
Third Quarter 2018 Financial Highlights
-- Revenue for the third quarter was $4.0 million in 2018, compared to $2.8 million in 2017.
-- The net loss for the quarter was $136,000 in 2018, or $0.00 per share, compared to a net loss for the quarter of $643,000, or $0.02 per share, for 2017.
Nine Months Ended September 30, 2018 Financial Highlights
-- Revenue for the first nine months of 2018 was $11.0 million, vs. $9.9 million reported during the same period of 2017.
-- The NET LOSS for the first nine months of 2018 was $1.0 million, or $0.03 per share, compared to a net loss of $0.6 million, or $0.02 per share, for the comparable period of 2017.
-- The Company finished the quarter with approximately $1.0 million in cash and cash equivalents.
Jankowski continued, "Our nine-month results were negatively impacted by what we believe was an anomalous first quarter, and for Q318, residual launch costs, and catch-up volume discounts accompanying the rapid growth from our largest personal care ingredients customer. That said, we are excited about our 2018 product launches and the growth we expect them to drive in 2019. We are expecting additional Solesence product launches in 2019 and continued strong volume for our active ingredients business for the foreseeable future."
Shareholders and members of the financial community are encouraged to participate in the upcoming conference call, where Mr. Jankowski will discuss the company's current and long-term prospects.
And so we are told this is the golden age
And gold is the reason for the wars we wage U2
Recent NANX News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:36:20 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/05/2024 09:11:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:06:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 09:00:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 09:00:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 09:58:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 10:54:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 11:00:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 09:00:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 09:00:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 09:00:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 09:00:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 09:00:09 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/22/2023 05:15:23 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 11/21/2023 10:25:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 11:00:17 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/06/2023 08:53:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/09/2023 12:00:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2023 12:00:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/01/2023 01:00:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/31/2023 10:40:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 12:00:09 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM